BCLI Insider Trading Activity and SEC Form 4 Filings
BCLI insider trading summary
No open-market insider purchases or sales of Brainstorm Cell Therapeutics Inc. (BCLI) have been reported on SEC Form 4 in the past 12 months.
Latest BCLI insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 1, 2024 | Chaim Lebovits | President & CEO | Buy | $6K (1,836 @ $3.43) |
| Sep 30, 2024 | Chaim Lebovits | President & CEO | Buy | $5K (22,000 @ $0.23) |
| Jul 19, 2024 | Ibrahim B. Dagher | Chief Medical Officer | Sell | $22K (63,000 @ $0.35) |
| Sep 1, 2023 | Stacy Lindborg | Co-Chief Executive Officer | Buy | $20K (11,500 @ $1.77) |
| Jul 16, 2020 | David Setboun | EVP and COO | Buy | $65K (5,000 @ $12.95) |
| Jul 16, 2020 | ACC International Holdings Ltd. | Insider | Sell | $105K (7,823 @ $13.47) |
| Jul 15, 2020 | ACC International Holdings Ltd. | Insider | Sell | $242K (18,430 @ $13.12) |
| Jul 15, 2020 | Sankesh Abbhi | Director | Buy | $608K (46,779 @ $12.99) |
| Jul 13, 2020 | ACC International Holdings Ltd. | Insider | Sell | $541K (40,000 @ $13.52) |
| Jul 10, 2020 | ACC International Holdings Ltd. | Insider | Sell | $27K (2,000 @ $13.35) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.